Home›Companies›Ironfist Therapeutics

Ironfist Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 20, 2025·Suggest an edit

About Ironfist Therapeutics

Ironfist Therapeutics is a private company based in Campbell, California, incorporated in 2025 in Delaware. It has reported $1,750 raised in one offering on Form D since October 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 4, 2025Oct 20, 2025$1,750of $1,800 target11$159EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ironfist Therapeutics's Form D filed Oct 20, 2025.

Jeffrey Cleland
Jeffrey Cleland
Executive officer, director and promoter
Also a director at Elixirgen Therapeutics and Syncromune and an executive officer, director and promoter at Nanopower Medicine.
JZ
Jay Zaveri
Executive officer, director and promoter
Also an executive officer, director and promoter at Nanopower Medicine.
AS
Arjun Sethi
Executive officer, director and promoter
Also an executive officer, director and promoter at Nanopower Medicine.

Sources

  1. SECIronfist Therapeutics, Inc. filing history